2.4.1.90 biotechnology enzyme can be useful in the glycosylation of cytokines, enzymes or other glycosylated compounds modifying their functions for use in medical therapies 658123 2.4.1.90 medicine an UDP-galactose: N-acetylglucosamine beta 1-4 galactosyltransferase expressing attenuated Leishmania donovani clonal population is able to confer protection against the experimental challenge with the virulent Leishmania donovani AG83 parasite -, 703923 2.4.1.90 medicine enzyme expression is an independent prognostic factor for poor survival of neuroblastoma patients 735973 2.4.1.90 medicine the enzyme serves as a diagnostic and therapeutic biomarker for the progression of human colorectal cancer 755974 2.4.1.90 synthesis - 489547 2.4.1.90 synthesis development of a method to tag glycoproteins carrying terminal GlcNAc using the enzyme, overview 690111 2.4.1.90 synthesis enzyme can be useful in the glycosylation of cytokines, enzymes or other glycosylated compounds modifying their functions for use in medical therapies 658123 2.4.1.90 synthesis preparation of a series of specific derivatives of the complex protopanaxadiol glycoside ginsenoside Rb1 489541 2.4.1.90 synthesis use of transformed whole yeast cells, expressing the human N-acetylglucosamine beta-1,4-galactosyltransferase, in synthesis of N-acetyllactosamine 489547